Comparison of Ultrasound-Guided Erector Spinae Plane Block and Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) for Postoperative Analgesia After Laparoscopic Cholecystectomy: A Randomized Controlled Study
2 other identifiers
interventional
80
1 country
1
Brief Summary
This study compared two ultrasound-guided regional anesthesia techniques for pain relief after laparoscopic gallbladder surgery: the modified thoracoabdominal nerve block through a perichondrial approach and the erector spinae plane block. Adults undergoing elective laparoscopic cholecystectomy under general anesthesia were randomly assigned to receive one of these two nerve blocks on both sides of the body before awakening from anesthesia. Both techniques used bupivacaine as the local anesthetic. After surgery, pain intensity, tramadol consumption, need for additional pain medication, nausea and vomiting, antiemetic use, and block-related complications were assessed during the first 24 postoperative hours. The main objective was to determine whether the two techniques differed in their ability to reduce postoperative tramadol consumption and provide effective pain relief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2025
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedAugust 7, 2026
August 1, 2026
9 months
August 3, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative Postoperative Tramadol Consumption During the First 24 Hours
The total amount of tramadol delivered through intravenous patient-controlled analgesia was calculated for each participant. The patient-controlled analgesia device was programmed to deliver a 15 mg tramadol bolus with a 15-minute lockout interval. Tramadol consumption recorded during the postoperative observation periods was summed and reported in milligrams. The standardized intraoperative tramadol dose administered to all participants was not included in this outcome.
From arrival in the post-anesthesia care unit through 24 hours after surgery
Secondary Outcomes (7)
Postoperative Pain Intensity Assessed Using the Visual Analog Scale
At post-anesthesia care unit arrival and 30 minutes, 2 hours, 3 hours, 6 hours, and 24 hours after surgery
Patient-Controlled Analgesia Demand Count
At post-anesthesia care unit arrival and 30 minutes, 2 hours, 3 hours, 6 hours, and 24 hours after surgery
Tramadol Consumption at Individual Postoperative Assessment Times
At post-anesthesia care unit arrival and 30 minutes, 2 hours, 3 hours, 6 hours, and 24 hours after surgery
Requirement for Additional Postoperative Analgesia
From post-anesthesia care unit arrival through 24 hours after surgery
Postoperative Nausea and Vomiting Score
At post-anesthesia care unit arrival and 30 minutes, 2 hours, 3 hours, 6 hours, and 24 hours after surgery
- +2 more secondary outcomes
Study Arms (2)
Bilateral Modified Thoracoabdominal Nerve Block Through Perichondrial Approach
EXPERIMENTALAfter removal of the gallbladder and before extubation, participants received a bilateral ultrasound-guided modified thoracoabdominal nerve block through a perichondrial approach. The block was performed at the inferior surface of the 10th costal cartilage using 0.25% bupivacaine. Participants also received the standardized general anesthesia and multimodal postoperative analgesia protocols used in both study arms.
Bilateral Erector Spinae Plane Block
ACTIVE COMPARATORAfter removal of the gallbladder and before extubation, participants received a bilateral ultrasound-guided erector spinae plane block at the T7 vertebral level. The local anesthetic was injected between the erector spinae muscle and the transverse process using 0.25% bupivacaine. Participants also received the standardized general anesthesia and multimodal postoperative analgesia protocols used in both study arms.
Interventions
After removal of the gallbladder and before extubation, the block was performed bilaterally under ultrasound guidance. The external oblique, internal oblique, and transversus abdominis muscles were identified at the inferior margin of the 10th costal cartilage. A block needle was advanced using an in-plane technique toward the inferior surface of the costal cartilage. After confirmation of the needle position with 2 to 3 mL of normal saline, 20 mL of 0.25% bupivacaine was administered on each side.
After removal of the gallbladder and before extubation, the block was performed bilaterally under ultrasound guidance at the T7 vertebral level. The needle was advanced using an in-plane technique until its tip was positioned between the erector spinae muscle and the transverse process. After confirmation of the needle position with 2 to 3 mL of normal saline, 20 mL of 0.25% bupivacaine was administered on each side.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia
- American Society of Anesthesiologists physical status I to III
- Body mass index below 35 kg/m²
- International Normalized Ratio and platelet count within the institutional reference ranges
- Liver and renal function test results within the institutional reference ranges
- Provision of written informed consent
You may not qualify if:
- Bleeding diathesis
- Known allergy to local anesthetics
- Infection or inflammation at the planned block application site
- Gallbladder perforation
- Known neurological disease
- American Society of Anesthesiologists physical status IV or higher
- Long-term medication use for chronic pain
- Advanced liver or renal failure
- Previous abdominal surgery or abdominal trauma
- Use of any opioid medication within 24 hours before surgery
- Pregnancy
- Refusal to participate
- Intraoperative conversion from laparoscopic to open surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Provincial Directorate of Health Sultan 2.Abdul Hamid Khan Educational and Research Hospital
Istanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 7, 2026
Study Start
February 20, 2025
Primary Completion
December 1, 2025
Study Completion
December 2, 2025
Last Updated
August 7, 2026
Record last verified: 2026-08